Hyperhomocysteinaemia is associated with coronary events in type 2 diabetes (Q44326347)

2 December 2017

title

Hyperhomocysteinaemia is associated with coronary events in type 2 diabetes (English)

1 reference

2 December 2017

1 reference

7

1 reference

2 December 2017

4

Heine RJ

1 reference

2 December 2017

6

Nijpels G

1 reference

2 December 2017

5

Dekker JM

1 reference

2 December 2017

8

Stehouwer CD

1 reference

2 December 2017

Becker A

1

1 reference

2 December 2017

Kostense PJ

series ordinal

2

1 reference

2 December 2017

Bos G

series ordinal

3

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

Journal of Internal Medicine

2 December 2017

published in

1 reference

2 December 2017

volume

253

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

293-300

1 reference

Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01113.X

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01113.X

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01113.X

Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes : 5-year follow-up of the Hoorn Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01113.X

Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01113.X

Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01113.X

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01113.X

Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01113.X

Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: a 10-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01113.X

Hyperhomocystinemia: a risk factor or a consequence of coronary heart disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01113.X

Homocysteine and cardiovascular disease in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01113.X

Homocysteine enhances impairment of endothelium-dependent relaxation and guanosine cyclic monophosphate formation in aortae from diabetic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01113.X

C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01113.X

Diabetes mellitus and hyperhomocysteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01113.X

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01113.X

Power Shortage: clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01113.X

Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01113.X

Underestimation of Risk Associations Due to Regression Dilution in Long-term Follow-up of Prospective Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01113.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01113.X

Hyperhomocysteinemia Is Associated With the Presence of Retinopathy in Type 2 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01113.X

Homocysteine and atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01113.X

Plasma homocysteine and all-cause mortality in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01113.X

Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01113.X

Plasma homocysteine levels and mortality in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01113.X

National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2003.01113.X

10.1046/J.1365-2796.2003.01113.X

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference